Nonetheless, the overall proportion of CD8+CD57+ NK cells expressing KIR2DL1 was increased in stable remission, particularly when compared with active disease (Figure 2C), allowing us to conclude that CD8+CD57+KIR2DL1+ NK cells in peripheral blood are associated with sustained RA remission. This evidence concerns the gene KIR2DL1 and rheumatoid arthritis.